Q4 2022 · 13F-HR
Cheyne Capital Management (UK) LLPholdings as filed
Filed 2023-02-10 · accession 0001567619-23-002236
$57.2M
Reported value
59
Positions
2022-12-31
Period end
Holdings as filed
| CUSIP | Ticker | Issuer | Value | % port. | Shares | Class | Voting |
|---|---|---|---|---|---|---|---|
| 00507V109 | AIY | ACTIVISION BLIZZARD INC | $7.9M | 13.8% | 103,136 | Common | SOLE |
| 165167735 | EXE | CHESAPEAKE ENERGY CORP. | $3.7M | 6.51% | 39,506 | Common | SOLE |
| 067901108 | ABX | BARRICK GOLD CORP. | $3.4M | 6.00% | 200,000 | Common | SOLE |
| 750491102 | RDNT | RADNET INC | $2.1M | 3.67% | 111,427 | Common | SOLE |
| 30744W107 | FTCHQ | FARFETCH LTD | $2.0M | 3.44% | 416,500 | Common | SOLE |
| 98420N105 | XENE | XENON PHARMACEUTICALS INC | $1.7M | 2.93% | 42,500 | Common | SOLE |
| 867224107 | SU | SUNCOR ENERGY INC NEW | $1.5M | 2.57% | 46,300 | Common | SOLE |
| 674599105 | OXY | OCCIDENTAL PETE CORP | $1.5M | 2.56% | 23,300 | Common | SOLE |
| 75382E109 | — | RAPT THERAPEUTICS INC | $1.4M | 2.49% | 71,828 | Common | SOLE |
| 00768Y453 | MSOS | ADVISORSHARES TR | $1.4M | 2.47% | 202,000 | Common | SOLE |
| 02083G100 | NVLSEUR | ALPINE IMMUNE SCIENCES INC | $1.3M | 2.34% | 181,886 | Common | SOLE |
| 44332N106 | HTHT | H WORLD GROUP LTD | $1.3M | 2.30% | 31,000 | Common | SOLE |
| 92243G108 | PCVX | VAXCYTE INC | $1.3M | 2.25% | 26,849 | Common | SOLE |
| 729139105 | PLRX | PLIANT THERAPEUTICS INC | $1.3M | 2.23% | 66,144 | Common | SOLE |
| G65431127 | NE | NOBLE CORP PLC | $1.2M | 2.12% | 32,100 | Common | SOLE |
| 090043100 | BILL | BILL COM HLDGS INC | $1.2M | 2.08% | 10,940 | Common | SOLE |
| 878742204 | TECK | TECK RESOURCES LTD | $1.1M | 1.86% | 28,100 | Common | SOLE |
| 81181C104 | — | SEAGEN INC | $1.0M | 1.80% | 8,025 | Common | SOLE |
| 15135U109 | CVE | CENOVUS ENERGY INC | $1.0M | 1.80% | 53,000 | Common | SOLE |
| 730541109 | — | POINT BIOPHARMA GLOBAL INC | $926,486 | 1.62% | 127,090 | Common | SOLE |
| 46583P102 | — | IVERIC BIO INC | $883,163 | 1.54% | 41,250 | Common | SOLE |
| 01609W102 | BABA | ALIBABA GROUP HLDG LTD | $863,282 | 1.51% | 9,800 | Common | SOLE |
| 008474108 | AEM | AGNICO EAGLE MINES LTD | $852,636 | 1.49% | 16,400 | Common | SOLE |
| 17240Y109 | — | CINCOR PHARMA INC | $830,276 | 1.45% | 67,557 | Common | SOLE |
| 13057Q305 | CRC | CALIFORNIA RES CORP | $817,335 | 1.43% | 18,785 | Common | SOLE |
| 00461U105 | ACRS | ACLARIS THERAPEUTICS INC | $802,683 | 1.40% | 50,964 | Common | SOLE |
| 427746102 | HRTX | HERON THERAPEUTICS INC | $795,020 | 1.39% | 318,008 | Common | SOLE |
| 90400D108 | RARE | ULTRAGENYX PHARMACEUTICAL IN | $792,938 | 1.39% | 17,115 | Common | SOLE |
| 68404V100 | — | OPTINOSE INC | $730,264 | 1.28% | 394,737 | Common | SOLE |
| 90353T100 | UBER | UBER TECHNOLOGIES INC | $722,116 | 1.26% | 29,200 | Common | SOLE |
| 92332V107 | VTYXUSD | VENTYX BIOSCIENCES INC | $656,948 | 1.15% | 20,035 | Common | SOLE |
| 92686J106 | VKTX | VIKING THERAPEUTICS INC | $608,678 | 1.06% | 64,753 | Common | SOLE |
| 23954D109 | DAWNGBX | DAY ONE BIOPHARMACEUTICALS I | $585,839 | 1.02% | 27,223 | Common | SOLE |
| 13321L108 | CCJ | CAMECO CORP | $582,619 | 1.02% | 25,700 | Common | SOLE |
| 69366J200 | PTCT | PTC THERAPEUTICS INC | $576,596 | 1.01% | 15,106 | Common | SOLE |
| 008064107 | — | AEROVATE THERAPEUTICS INC | $554,561 | 0.97% | 18,927 | Common | SOLE |
| 674599105 | OXY | OCCIDENTAL PETE CORP | $536,050 | 0.94% | 302 | CALL | SOLE |
| 697900108 | PAAS | PAN AMERN SILVER CORP | $503,272 | 0.88% | 30,800 | Common | SOLE |
| 89422G107 | TVTX | TRAVERE THERAPEUTICS INC | $499,463 | 0.87% | 23,750 | Common | SOLE |
| 23257D103 | CBAYUSD | CYMABAY THERAPEUTICS INC | $485,919 | 0.85% | 77,499 | Common | SOLE |
| 803607100 | SRPT | SAREPTA THERAPEUTICS INC | $472,967 | 0.83% | 3,650 | Common | SOLE |
| 26884L109 | EQT | EQT CORP | $412,726 | 0.72% | 12,200 | Common | SOLE |
| 483497103 | KALV | KALVISTA PHARMACEUTICALS INC | $356,860 | 0.62% | 52,790 | Common | SOLE |
| 03237H101 | AMLX | AMYLYX PHARMACEUTICALS INC | $350,988 | 0.61% | 9,499 | Common | SOLE |
| 61559X104 | MLTX | MOONLAKE IMMUNOTHERAPEUTICS | $337,355 | 0.59% | 32,129 | Common | SOLE |
| 45845P108 | — | INTERCEPT PHARMACEUTICALS IN | $327,100 | 0.57% | 26,443 | Common | SOLE |
| 00509G209 | ABOS | ACUMEN PHARMACEUTICALS INC | $301,477 | 0.53% | 55,829 | Common | SOLE |
| 60468T105 | MRTXEUR | MIRATI THERAPEUTICS INC | $301,312 | 0.53% | 6,650 | Common | SOLE |
| 92539P101 | — | VERVE THERAPEUTICS INC | $290,250 | 0.51% | 15,000 | Common | SOLE |
| 01345P106 | BDQM | ALBIREO PHARMA INC | $288,796 | 0.50% | 13,364 | Common | SOLE |
| 517125100 | LRMR | LARIMAR THERAPEUTICS INC | $262,998 | 0.46% | 63,680 | Common | SOLE |
| 08579X101 | BRY | BERRY CORP | $248,000 | 0.43% | 31,000 | Common | SOLE |
| 01675A109 | BIRDGBP | ALLBIRDS INC | $242,000 | 0.42% | 100,000 | Common | SOLE |
| 74019P108 | — | PRECISION BIOSCIENCES INC | $226,177 | 0.40% | 190,065 | Common | SOLE |
| 38406L103 | — | GRACELL BIOTECHNOLOGIES INC | $225,676 | 0.39% | 98,120 | Common | SOLE |
| 75281A109 | RRC | RANGE RES CORP | $225,180 | 0.39% | 9,000 | Common | SOLE |
| 845467109 | SWN1EUR | SOUTHWESTERN ENERGY CO | $216,450 | 0.38% | 37,000 | Common | SOLE |
| 37148K100 | GBIOGBX | GENERATION BIO CO | $200,925 | 0.35% | 51,126 | Common | SOLE |
| 55910K108 | — | MAGENTA THERAPEUTICS INC | $18,632 | 0.03% | 47,170 | Common | SOLE |
Source: SEC EDGAR · raw 13F holdings as filed. The Class column shows the option type when reported (Put/Call) or Common when the issuer's equity is held directly. 13F discloses long positions only.